Quantbot Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Quantbot Technologies’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,400	Closed	-$78K	–	1766
2022 Q2	$78K	Buy	1,400 +700	+100%	+$41.5K	0.01%	1204
2022 Q1	$43K	Sell	700 -6,765	-91%	-$414K	﹤0.01%	1230
2021 Q4	$411K	Buy	7,465 +1,752	+31%	+$91.4K	0.03%	581
2021 Q3	$300K	Buy	+5,713	New	+$339K	0.02%	721
2021 Q2	–	Sell	-2,300	Closed	-$177K	–	1590
2021 Q1	$177K	Buy	2,300 +1,900	+475%	+$175K	0.02%	746
2020 Q4	$39K	Sell	400 -100	-20%	-$12.2K	﹤0.01%	900
2020 Q3	$70K	Buy	+500	New	+$83.4K	0.01%	797
2018 Q4	–	Sell	-820	Closed	-$92K	–	1159
2018 Q3	$92K	Sell	820 -743	-48%	-$78.5K	0.01%	900
2018 Q2	$144K	Buy	1,563 +418	+37%	+$40.6K	0.01%	802
2018 Q1	$114K	Buy	1,145 +379	+49%	+$40.9K	0.01%	815
2017 Q4	$71K	Buy	766 +618	+418%	+$58.5K	0.01%	914
2017 Q3	$15K	Buy	+148	New	+$12.9K	﹤0.01%	1072
2017 Q1	–	Sell	-797	Closed	-$51K	–	1235
2016 Q4	$51K	Buy	+797	New	+$49K	0.01%	832

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Quantbot Technologies's LKFT Position: Q3 2022 in Review

Quantbot Technologies sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022, closing a stake of 1,400 shares — an estimated $78K sold.

Quantbot Technologies first reported a position in LKFT in Q4 2016 and held it in 13 quarters. The position peaked at $411K in Q4 2021. 83 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.

Quantbot Technologies reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Quantbot Technologies sold 1,400 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2022, an estimated $78K.
Quantbot Technologies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 13 quarters.
Quantbot Technologies's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q4 2021.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.